Skip to main content

Research Repository

Advanced Search

Regional increase in the expression of the BCAT proteins in Alzheimer's disease brain: Implications in glutamate toxicity

Hull, Jonathon; Patel, Vinood; El Hindy, Maya; Lee, Christopher; Odeleye, Esther; Hezwani, Mohammed; Love, Seth; Kehoe, Patrick; Chalmers, Katy; Conway, Myra


Jonathon Hull
Senior Lecturer in Biomedical Sci (Biochemistry)

Vinood Patel

Maya El Hindy

Christopher Lee

Esther Odeleye

Mohammed Hezwani

Seth Love

Patrick Kehoe

Katy Chalmers

Myra Conway
Occasional Associate Lecturer - HAS DAS


© 2015 - IOS Press and the authors. All rights reserved. Background: The human branched chain aminotransferases (hBCATm, mitochondrial and hBCATc, cytosolic) are major contributors to brain glutamate production. This excitatory neurotransmitter is thought to contribute to neurotoxicity in neurodegenerative conditions such as Alzheimer's disease (AD) but the expression of hBCAT in this disease has not previously been investigated. Objective: The objective of investigating hBCAT expression is to gain insight into potential metabolic pathways that may be dysregulated in AD brain, which would contribute to glutamate toxicity. Methods: Western blot analysis and immunohistochemistry were used to determine the expression and localization of hBCAT in postmortem frontal and temporal cortex from AD and matched control brains. Results: Western blot analysis demonstrated a significant regional increase in hBCATc expression in the hippocampus (↑ 36%; p-values of 0.012), with an increase of ↑ 160% reported for hBCATm in the frontal and temporal cortex (p-values = 4.22 × 10-4 and 2.79 × 10-5, respectively) in AD relative to matched controls, with evidence of post-translational modifications to hBCATm, more prominent in AD samples. Using immunohistochemistry, a significant increase in immunopositive labelling of hBCATc was observed in the CA1 and CA4 region of the hippocampus (p-values = 0.011 and 0.026, respectively) correlating with western blot analysis. Moreover, the level of hBCATm in the frontal and temporal cortex correlated significantly with disease severity, as indicated by Braak staging (p-values = 5.63 × 10-6 and 9.29 × 10-5, respectively). Conclusion: The expression of the hBCAT proteins is significantly elevated in AD brain. This may modulate glutamate production and toxicity, and thereby play a role in the pathogenesis of the disease.


Hull, J., Patel, V., El Hindy, M., Lee, C., Odeleye, E., Hezwani, M., …Conway, M. (2015). Regional Increase in the Expression of the BCAT Proteins in Alzheimer's Disease Brain: Implications in Glutamate Toxicity. Journal of Alzheimer's Disease, 45(3), 891-905.

Journal Article Type Article
Acceptance Date Jan 6, 2015
Publication Date Jun 1, 2015
Journal Journal of Alzheimer's Disease
Print ISSN 1387-2877
Publisher IOS Press
Peer Reviewed Peer Reviewed
Volume 45
Issue 3
Pages 891-905
Keywords Alzheimer's disease, glutamate metabolism, hBCAT
Public URL
Publisher URL


You might also like

Downloadable Citations